Johnson & Johnson (NYSE:JNJ) ~ A Busy Week for Cardiac Health at the FDA

January 06, 2014 at 13:15 PM EST

[at Motley Fool] – Chelsea, Merck, and Johnson & Johnson state their cases for approval in front of an FDA panel. Here’s everything you need to know to stay ahead of the game. . . . → Read More: Johnson & Johnson (NYSE:JNJ) ~ A Busy Week for Cardiac Health at the FDA Similar posts: Merck & Co. Inc. (NYSE:MRK) ~ A Busy Week for Cardiac Health at the FDA Johnson & Johnson (NYSE:JNJ) | Keep an Eye on Biogen, Johnson & Johnson, and Merck Today Stocks rise on health plan approval in US, USD loses strength

Johnson & Johnson (NYSE:JNJ) [at Motley Fool] – Chelsea, Merck, and Johnson & Johnson state their cases for approval in front of an FDA panel. Here’s everything you need to know to stay ahead of the game.
Read more on this.

Johnson & … [visit site to read more]